$CL earnings report

Colgate-Palmolive Announces 3rd Quarter 2026 Results. AlphAI read Colgate Palmolive's third quarter 2026 filing as solid. 2 quarters are on record below.

third quarter 2026

AlphAI · Earnings readCL · third quarter 2026 · ended September 30, 2026

Colgate-Palmolive Announces 3rd Quarter 2026 Results

✓Solid quarter

Third-quarter net sales increased 4.6%, organic sales growth was +3.6%, GAAP diluted EPS increased 3% to $0.94 and Base Business diluted EPS increased 7% to $0.97. Gross profit margin expanded, while North America sales declined and reported operating profit margin contracted.

Revenue
$5.37B
+4.6 % y/y
North America, three months ended September 30
$905M
(1.7) % y/y
Full Year 2026 outlook
net sales to be up 4% to 5%, including a low-single-digit positive impact from foreign exchange; organic sales growth to be broadly in line with its nine-month performance
GM GAAP gross profit margin to be up; non-GAAP (Base Business) gross profit margin to be up

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net sales, three months ended September 30GAAP$5.37B–+4.6 %
Organic sales growth, three months ended September 30non-GAAP+3.6 %–+3.6 %
Gross profit, three months ended September 30GAAP$3.23B––
Gross profit, three months ended September 30non-GAAP$3.24B––
Gross profit margin, three months ended September 30GAAP60.2 %–80 basis points
Gross profit margin, three months ended September 30non-GAAP60.3 %–90 basis points
Selling, general and administrative expenses, three months ended September 30GAAP$2.11B––
Selling, general and administrative expenses as a percentage of Net sales, three months ended September 30GAAP39.3 %–90 basis points
Operating profit, three months ended September 30GAAP$1.09B–3 %
Operating profit, three months ended September 30non-GAAP$1.12B–5 %
Operating profit margin, three months ended September 30GAAP20.3 %–(30) basis points
Operating profit margin, three months ended September 30non-GAAP20.8 %–20 basis points
Net income attributable to Colgate-Palmolive Company, three months ended September 30GAAP$751M––
Net income attributable to Colgate-Palmolive Company, three months ended September 30non-GAAP$777M––
Diluted earnings per common share, three months ended September 30GAAP$0.94–+3 %
Diluted earnings per common share, three months ended September 30non-GAAP$0.97–+7 %
Effective tax rate, three months ended September 30GAAP23.6 %––
Effective tax rate, three months ended September 30non-GAAP23.3 %––
Advertising, three months ended September 30GAAP$775M––
Net sales, nine months ended September 30GAAP$16.05B–6.0 %
Organic sales growth, nine months ended September 30non-GAAP3.0 %–3.0 %
Gross profit, nine months ended September 30GAAP$9.76B––
Gross profit margin, nine months ended September 30GAAP60.8 %––
Operating profit, nine months ended September 30GAAP$3.07B–(5) %
Operating profit, nine months ended September 30non-GAAP$3.40B–5 %
Operating profit margin, nine months ended September 30GAAP19.1 %–(210) basis points
Operating profit margin, nine months ended September 30non-GAAP21.2 %–(20) basis points
Net income attributable to Colgate-Palmolive Company, nine months ended September 30GAAP$2.09B––
Net income attributable to Colgate-Palmolive Company, nine months ended September 30non-GAAP$2.36B––
Diluted earnings per common share, nine months ended September 30GAAP$2.61––
Diluted earnings per common share, nine months ended September 30non-GAAP$2.94––
Net cash provided by operations, nine months ended September 30GAAP$2.91B––
Free cash flow before dividends, nine months ended September 30non-GAAP$2.51B––

Segments

SegmentRevenueq/qy/y
North America, three months ended September 30Organic sales change was (1.6) %, with volume of (3.7) %, pricing of 2.2 % and foreign exchange of (0.2) %.$905M–(1.7) %
Latin America, three months ended September 30Organic sales change was 6.0 %, with volume of 3.9 %, pricing of 2.1 % and foreign exchange of 6.5 %.$1.33B–12.5 %
Europe, Middle East & Africa, three months ended September 30Organic sales change was 2.7 %, with volume of 3.5 %, pricing of (0.9) % and foreign exchange of (1.2) %.$1.13B–1.4 %
Asia Pacific, three months ended September 30Organic sales change was 4.6 %, with volume of 1.9 %, pricing of 2.8 % and foreign exchange of (1.1) %.$802M–3.5 %
Hill's Pet Nutrition, three months ended September 30Organic sales change was 5.7 %, with volume of 1.8 %, pricing of 3.9 % and foreign exchange of (0.1) %.$1.21B–5.6 %
North America, nine months ended September 30Organic sales change was (2.3) %, with volume of (3.6) %, pricing of 1.4 % and foreign exchange of 0.1 %.$2.68B–(2.2) %
Latin America, nine months ended September 30Organic sales change was 5.6 %, with volume of 2.8 %, pricing of 2.7 % and foreign exchange of 8.1 %.$4.01B–13.7 %
Europe, Middle East & Africa, nine months ended September 30Organic sales change was 2.7 %, with volume of 3.0 %, pricing of (0.3) % and foreign exchange of 2.8 %.$3.38B–5.4 %
Asia Pacific, nine months ended September 30Organic sales change was 5.1 %, with volume of 3.5 %, pricing of 1.6 % and foreign exchange of 0.6 %.$2.39B–5.7 %
Hill's Pet Nutrition, nine months ended September 30Organic sales change was 3.3 %, with organic volume of (0.6) %, pricing of 3.9 % and foreign exchange of 1.1 %.$3.59B–5.2 %

Amounts quoted below without a unit are in millions, as in the filing’s tables. Per-share figures are as printed.

Full Year 2026 outlook

  • Revenuenet sales to be up 4% to 5%, including a low-single-digit positive impact from foreign exchange; organic sales growth to be broadly in line with its nine-month performance
  • Gross marginGAAP gross profit margin to be up; non-GAAP (Base Business) gross profit margin to be up
  • NoteGAAP advertising to be up on both a dollar basis and as a percentage of net sales.
  • NoteGAAP double-digit earnings per share growth.
  • NoteNon-GAAP (Base Business) advertising to be up on both a dollar basis and as a percentage of net sales.
  • NoteNon-GAAP (Base Business) earnings per share growth of 5% to 7%.
  • NoteOrganic sales growth includes the impact from the exit from the private label pet food business.

Capital returns

  • Dividends paid were $1,308 for the nine months ended September 30, 2026, compared with $1,300 for the nine months ended September 30, 2025.
  • Purchases of treasury shares were $927 for the nine months ended September 30, 2026, compared with $804 for the nine months ended September 30, 2025.
  • Proceeds from exercise of stock options were $178 for the nine months ended September 30, 2026, compared with $83 for the nine months ended September 30, 2025.

What drove it

  • Third-quarter Total Company volume was +1.7 %, pricing was +2.0 % and foreign exchange was +1.0 %.
  • Latin America delivered 12.5 % net sales growth, including 6.5 % from foreign exchange.
  • Hill's Pet Nutrition delivered 5.6 % net sales growth and 5.7 % organic sales growth.
  • The Company reported its fourth quarter of sequential improvement in worldwide volume growth.
  • Advertising was $775 in the third quarter, compared with $674 in the prior-year quarter.
  • Global toothpaste market share was 41.4% year to date and global manual toothbrush market share was 33.1% year to date.

Concerns

  • North America third-quarter net sales declined (1.7) % and organic sales change was (1.6) %.
  • North America third-quarter operating profit was $177, down 11%, and operating profit margin was 19.5%, down 210 basis points.
  • Third-quarter GAAP operating profit margin was 20.3 %, compared with 20.6 % in the prior-year quarter.
  • Nine-month GAAP operating profit was $3,069, down (5) %, while GAAP operating profit margin was 19.1 %, compared with 21.2 %.
  • Nine-month GAAP net income attributable to Colgate-Palmolive Company was $2,090, compared with $2,169, and diluted EPS was $2.61, compared with $2.67.
  • The guidance cites consumer uncertainty and ongoing macroeconomic volatility.

What to watch

  • Full-year net sales guidance of up 4% to 5%, narrowed from 2% to 6%.
  • Full-year organic sales growth expected to be broadly in line with nine-month performance, including the impact from the exit from the private label pet food business.
  • Delivery of full-year GAAP and Base Business gross profit margin expansion after prior guidance of roughly flat.
  • Full-year Base Business earnings per share growth guidance of 5% to 7%, raised from mid-single-digit growth.
  • North America volume, which was (3.7) % in the third quarter.
  • The effect of a low-single-digit positive impact from foreign exchange in full-year net sales guidance.

Balance sheet and cash flow

  • Cash and cash equivalents were $1,527 as of September 30, 2026, compared with $1,288 as of December 31, 2025 and $1,279 as of September 30, 2025.
  • Total debt was $7,716 as of September 30, 2026, compared with $7,988 as of December 31, 2025 and $8,419 as of September 30, 2025.
  • Debt less cash, cash equivalents and marketable securities was $6,104 as of September 30, 2026, compared with $6,593 as of December 31, 2025 and $6,947 as of September 30, 2025.
  • Working capital % of sales was (6.3) % as of September 30, 2026, compared with (7.0) % as of December 31, 2025 and (4.0) % as of September 30, 2025.
  • Capital expenditures were $400 for the nine months ended September 30, 2026, compared with $387 for the nine months ended September 30, 2025.
  • Net cash used in financing activities was $(2,272) for the nine months ended September 30, 2026, compared with $(1,895) for the nine months ended September 30, 2025.
  • Net increase in Cash and cash equivalents was $239 for the nine months ended September 30, 2026, compared with $183 for the nine months ended September 30, 2025.

Analysis

Colgate-Palmolive reported a solid third quarter, with net sales of $5,369, up 4.6 %, and organic sales growth of +3.6 %. Total Company growth reflected +1.7 % volume, +2.0 % pricing and +1.0 % foreign exchange. Management stated that net sales and organic sales increased in all four categories and in four of five divisions. The major exception was North America, where net sales declined (1.7) % and volume declined (3.7) %.

The regional mix was led by Latin America, where net sales increased 12.5 %, including 6.5 % from foreign exchange, while organic sales increased 6.0 %. Hill's Pet Nutrition grew net sales 5.6 % and organic sales 5.7 %, supported by 1.8 % volume and 3.9 % pricing. Europe, Middle East & Africa and Asia Pacific also delivered positive organic growth. North America remains the clear weak point: its operating profit declined 11% to $177 and its operating profit margin contracted 210 basis points to 19.5%.

Margins improved at the gross-profit level but not on a reported operating-margin basis. GAAP gross profit margin increased 80 basis points to 60.2 %, and Base Business gross profit margin increased 90 basis points to 60.3 %. Advertising rose to $775 from $674. GAAP operating profit increased 3% to $1,088, but GAAP operating profit margin declined 30 basis points to 20.3 % as selling, general and administrative expenses as a percentage of Net sales rose to 39.3 % from 38.4 %. Base Business operating profit increased 5% to $1,117 and Base Business operating profit margin increased 20 basis points to 20.8 %.

Third-quarter GAAP diluted EPS increased 3% to $0.94 and Base Business diluted EPS increased 7% to $0.97. For the nine months, sales were $16,055 versus $15,152, but GAAP operating profit was $3,069 versus $3,214 and GAAP diluted EPS was $2.61 versus $2.67. Strategic Growth and Productivity Program charges affected nine-month GAAP results, while nine-month non-GAAP operating profit increased 5% to $3,396 and non-GAAP diluted EPS was $2.94 versus $2.74.

Cash generation and shareholder distributions remained material. Net cash provided by operations was $2,913 for the first nine months, and free cash flow before dividends was $2,513. The Company paid $1,308 in dividends and purchased $927 of treasury shares. Cash and cash equivalents were $1,527 and total debt was $7,716 as of September 30, 2026.

The Company narrowed full-year net sales guidance to up 4% to 5% from 2% to 6%, raised its gross profit margin outlook from roughly flat to up on both a GAAP and Base Business basis, and raised Base Business EPS growth guidance to 5% to 7% from mid-single-digit growth. It retained an expectation for GAAP double-digit earnings per share growth. Execution in North America, delivery of margin expansion, the exit from private label pet food, and the contribution from foreign exchange are the principal reported variables to monitor.

Management, verbatim

Our growth momentum continued, delivering another strong quarter of broad-based top- and bottom-line growth with net sales and organic sales increasing in all four categories and in four of five divisions. We were particularly pleased to have delivered our fourth quarter of sequential improvement in worldwide volume growth, while delivering strong pricing growth in the third quarter. As was the case last quarter, gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year.

Noel Wallace, Chairman, President and Chief Executive Officer

We remain focused on executing our 2030 strategy, with an emphasis on driving premium, science-based innovation, and we continue to invest behind our brands globally supported by another double-digit increase in advertising this quarter.

Noel Wallace, Chairman, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Prior-quarter values for key income-statement metrics were not reported.
  • Full-year 2026 operating-expense guidance was not reported.
  • Full-year 2026 tax-rate guidance was not reported.
  • A previous-release outlook section was not provided, so no actual-versus-prior-guidance comparison is included.
  • Third-quarter free cash flow before dividends was not reported.
  • Third-quarter cash flow from operations was not reported.
  • Third-quarter capital returns were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

second quarter 2026

AlphAI · Earnings readCL · second quarter 2026

Net sales increased 4.9% and Base Business EPS increased 8%, while GAAP EPS decreased 5%; full-year sales guidance was maintained and gross profit margin and Base Business EPS guidance were updated.

→Mixed quarter

Sales, organic sales, gross profit margin and Base Business EPS increased, but GAAP EPS decreased 5%, North America net sales declined, and Hill’s Pet Nutrition organic volume declined.

Revenue
$5.36B
+4.9 % y/y
North America
-3.0%
-3.0% y/y
EPS · non-GAAP
$0.99
+8 % y/y
full year 2026 outlook
net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange; organic sales growth to be 1% to 4%
GM GAAP gross profit margin to be roughly flat; non-GAAP (Base Business) gross profit margin to be roughly flat

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net SalesGAAP$5.36B–+4.9 %
EPS (diluted)GAAP$0.86–-5 %
Organic Sales Growthnon-GAAP+2.4 %––
Base Business EPS (diluted)non-GAAP$0.99–+8 %
Gross profit marginGAAP61.5%–increased 140 basis points
Base Business Gross profit marginnon-GAAP61.5%–increased 140 basis points
Operating Profit - North AmericaGAAP$192M–3%
Operating Profit - Latin AmericaGAAP$418M–14%
Operating Profit - Europe, Middle East & AfricaGAAP$263M–9%
Operating Profit - Asia PacificGAAP$209M–3%
Operating Profit - Hill’s Pet NutritionGAAP$269M–2%
Operating Profit - Total Company, As ReportedGAAP$1.02B–-6%
Operating Profit - Total Company, Base Businessnon-GAAP$1.15B–5%
Global toothpaste market share year to dateother41.3%––
Global manual toothbrushes market share year to dateother32.7%––
Advertising increaseother15%––
Net cash provided by operationsGAAP$1.74B––

Segments

SegmentRevenueq/qy/y
North AmericaAs Reported Volume -3.9%; Organic Volume -3.9%; Pricing +0.9%; FX —%.-3.0%–-3.0%
Latin AmericaOrganic Sales +5.3%; As Reported Volume +2.6%; Organic Volume +2.6%; Pricing +2.8%; FX +8.4%.+13.7%–+13.7%
Europe, Middle East & AfricaOrganic Sales +2.0%; As Reported Volume +3.2%; Organic Volume +3.2%; Pricing -1.2%; FX +1.6%.+3.5%–+3.5%
Asia PacificOrganic Sales +5.2%; As Reported Volume +4.1%; Organic Volume +4.1%; Pricing +1.1%; FX -0.3%.+4.9%–+4.9%
Hill’s Pet NutritionOrganic Sales +2.1%; As Reported Volume -1.2%; Organic Volume -1.8%; Pricing +3.9%; FX +0.6%. The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.6%.+3.4%–+3.4%
Total CompanyOrganic Sales +2.4%; As Reported Volume +0.9%; Organic Volume +0.8%; Pricing +1.6%; FX +2.4%. The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.1%.+4.9%–+4.9%

Amounts quoted below without a unit are in millions, as in the filing’s tables. Per-share figures are as printed.

full year 2026 outlook

  • Revenuenet sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange; organic sales growth to be 1% to 4%
  • Gross marginGAAP gross profit margin to be roughly flat; non-GAAP (Base Business) gross profit margin to be roughly flat
  • NoteGAAP advertising to be up on both a dollar basis and as a percentage of net sales.
  • NoteGAAP double-digit earnings per share growth.
  • NoteNon-GAAP (Base Business) advertising to be up on both a dollar basis and as a percentage of net sales.
  • NoteNon-GAAP (Base Business) mid-single-digit earnings per share growth.
  • NoteOrganic sales growth guidance includes the impact from the exit from the private label pet food business.

What drove it

  • Total Company organic sales growth was +2.4%, with pricing of +1.6% and organic volume of +0.8%.
  • Net sales and organic sales grew in three of four categories and in four of five divisions.
  • Worldwide organic volume growth improved sequentially for the third consecutive quarter.
  • Latin America delivered +13.7% net sales growth, including +8.4% FX and +5.3% organic sales growth.
  • Asia Pacific delivered +5.2% organic sales growth.
  • The Company continued to invest in the business, with advertising up 15% this quarter.
  • The Company cited global toothpaste market share of 41.3% year to date and global manual toothbrush market share of 32.7% year to date.

Concerns

  • GAAP EPS decreased 5% to $0.86.
  • North America net sales decreased -3.0%, with as reported volume and organic volume both down -3.9%.
  • Hill’s Pet Nutrition organic volume decreased -1.8% and as reported volume decreased -1.2%.
  • Organic sales growth included a 0.4% negative impact from lower private label pet food sales.
  • Total Company, As Reported operating profit declined -6% and operating profit margin declined -210 basis points.
  • Management expects volatile market conditions to continue in the balance of 2026.

What to watch

  • Delivery against full-year net sales guidance of up 2% to 6% and organic sales growth guidance of 1% to 4%.
  • Whether gross profit margin is roughly flat for full year 2026, following a 140-basis-point increase to 61.5% in the second quarter.
  • Progress in North America volume following the -3.9% decline in both as reported and organic volume.
  • Hill’s Pet Nutrition volume performance and the impact from the exit from the private label pet food business.
  • The effect of continued advertising investment, which management expects to be up on both a dollar basis and as a percentage of net sales.
  • Execution against non-GAAP (Base Business) mid-single-digit earnings per share growth guidance.

Balance sheet and cash flow

  • Net cash provided by operations was $1,742 million for the first six months of 2026.
  • Free cash flow increased year over year, but the filing text does not provide the amount or comparison.

Analysis

Colgate-Palmolive reported second-quarter net sales of $5,361, up +4.9 %, while organic sales growth was +2.4 %. Pricing contributed +1.6% and organic volume contributed +0.8% at the Total Company level. Foreign exchange added +2.4% to net sales growth. The company stated that net sales and organic sales grew in three of four categories and in four of five divisions, while worldwide organic volume growth improved sequentially for the third consecutive quarter.

Regional performance was uneven. Latin America posted +13.7% net sales growth and +5.3% organic sales growth, while Asia Pacific posted +4.9% net sales growth and +5.2% organic sales growth. Europe, Middle East & Africa reported +3.5% net sales growth and +2.0% organic sales growth. North America was the key weak division, with net sales down -3.0% and both as reported and organic volume down -3.9%. Hill’s Pet Nutrition grew net sales +3.4% and organic sales +2.1%, but organic volume fell -1.8%; lower private label pet food sales had a 0.4% negative impact on total organic sales growth.

Profit measures show a distinction between reported and Base Business results. GAAP EPS declined -5 % to $0.86, while Base Business EPS increased +8 % to $0.99. GAAP gross profit margin and Base Business gross profit margin each increased 140 basis points to 61.5%. Total Company, As Reported operating profit was $1,016, down -6%, and its margin was 19.0%, down -210 basis points. Total Company, Base Business operating profit was $1,145, up 5%, and its margin was 21.4%, up +10 basis points.

The company continued to invest in demand generation, reporting a 15% increase in advertising during the quarter. It also reported net cash provided by operations of $1,742 million for the first six months of 2026, while stating that free cash flow increased year over year. Market-share indicators remained prominent, with global toothpaste market share at 41.3% year to date and global manual toothbrush market share at 32.7% year to date.

For full year 2026, Colgate maintained guidance for net sales to be up 2% to 6% and organic sales growth of 1% to 4%. It now expects GAAP and Base Business gross profit margin to be roughly flat, versus down previously. GAAP double-digit EPS growth guidance was maintained, while Base Business EPS growth guidance was raised to mid-single-digit growth from low- to mid-single-digit growth previously. Management also expects advertising to be up on both a dollar basis and as a percentage of net sales, while citing volatile market conditions for the balance of 2026.

Management, verbatim

Our growth momentum continued in the second quarter, as we delivered strong broad-based top- and bottom-line results, despite a difficult operating environment. Net sales and organic sales grew in three of four categories and in four of five divisions with worldwide organic volume growth improving sequentially for the third consecutive quarter. Gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year.

Noel Wallace, Chairman, President and Chief Executive Officer

We delivered these strong results while continuing to invest in the long-term health of our business with a 15% increase in advertising this quarter. Strong levels of investment will continue in the back half of the year as we execute against our 2030 strategy with a focus on premium, science-led innovation and omni-channel demand generation to drive brand health and category growth.

Noel Wallace, Chairman, President and Chief Executive Officer

While we expect the volatile market conditions to continue in the balance of 2026, we are confident that the strength of our global portfolio and clear business strategy should enable us to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.

Noel Wallace, Chairman, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Period-end date for the second quarter of 2026.
  • GAAP net income and prior-year GAAP net income.
  • GAAP gross profit dollars and prior-year gross profit dollars.
  • Base Business gross profit margin prior-year percentage.
  • GAAP operating income prior-year amount.
  • GAAP total operating profit reconciliation items.
  • Segment net sales dollar amounts and prior-year segment net sales dollar amounts.
  • Prior-year and prior-quarter values for segment operating profit.
  • Free cash flow amount and prior-year free cash flow amount.
  • Cash, debt and other balance-sheet balances.
  • Share repurchases, dividends and other capital-return amounts.
  • Operating expenses guidance.
  • Tax-rate guidance.
  • Prior outlook document needed for formal actual-versus-prior-guidance comparisons.
  • Quantitative drivers of the GAAP EPS decline.
  • Quantitative drivers of gross profit margin expansion.
  • Category-level sales and volume metrics.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about CL earnings dates

When is Colgate Palmolive's next earnings date?
AlphAI has no date for CL yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.